N/A N=251 COVID-19 Vaccine Uptake Trial
Vaccination Refusal · COVID-19
Primary: Vaccine Uptake — 1; 3; 1; 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=2,868 Increasing Vaccine Uptake Among Adolescents in the Rural South
Vaccine Hesitancy
Primary: Difference in the Percentage of Adolescents Who Ever Received at Least One Dose of HPV Vaccination in the Intervention Group After the Intervention Implementation…
N/A N=2,701 COVID-19 Vaccination Take-Up
Covid19 · Vaccination
Primary: Rate of COVID-19 Vaccination at 1 Month — 12; 4; 0; 1 Participants
Phase 4 N=292 Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
Influenza
Primary: Number of Participants Who Received Influenza Vaccine. — 250 participants
N/A N=1,934 Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
COVID-19 Vaccines · Telemedicine · Vaccine Hesitancy
Primary: Proportion of Children Who Complete COVID-19 Vaccination, as Verified in State, Clinic, or Participant-held Records — 13; 7 Participants
N/A N=935 A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
Human Papillomavirus
Primary: Number of Students Who Initiated the HPV Vaccine Series as a Result of the School-based Program — 315 participants
N/A N=228,831 Precision Vaccine Promotion in Underserved Populations
Influenza · Vaccine Hesitancy
Primary: Number of Participants Vaccinated at the End of the Campaign Period — 33357; 854 Participants — p=0.216
Phase 4 N=56 Postpartum HPV Vaccination
HPV-Related Malignancy
Primary: Patient Indication of Willingness to Accept the Vaccine Based on Survey — 56 Participants
Phase 3 N=216 Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
Vaccination
Primary: GARDASIL Vaccination Uptake and Compliance With Second and Third Doses — 12; 12; 8; 3 participants — p=>.05
N/A N=23,768 Improving COVID-19 Vaccine Uptake in Nursing Homes
COVID-19 Vaccines
Primary: Number of Residents Who Received SARS-CoV-2 Vaccine — 3083; 2994 Participants
N/A N=510 Promoting Altruism to Enhance Vaccine Acceptance
Vaccine Refusal
Primary: Change in Vaccine Hesitancy Scores Pre- and Post-Intervention. — -0.4 units on a scale
N/A N=647 HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Human Papilloma Virus Infection Type 11 · Human Papilloma Virus Infection Type 16 · Human Papilloma Virus Infection Type 18
Primary: First Dose HPV Vaccine Uptake — 118; 63; 117 Participants
N/A N=312 CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
COVID-19 · Vaccine Refusal
Primary: Percentage of Participants Who Plan to Receive a COVID-19 Vaccine Post-intervention — 19; 24; 19; 21 Participants
N/A N=60 VISTA: Vaccinator-Initiated Screening and TAilored Counseling for Reducing Vaccine Hesitancy
Vaccination Uptake
Primary: Percentage of Women With Reduced Number of Concerns Immediately Post-counseling in the Intervention Arm — 51.72 percentage of women
N/A N=148 Healthy, Immunized Communities Study
Vaccine Hesitancy · Communicable Diseases in Children
Primary: Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV) — 74.3; 83.3; 97.9; 93.0 percentage of participants
N/A N=2,554 Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
Papillomavirus Vaccines
Primary: Human Papillomavirus or HPV-vaccine-dose Receipt — 782; 578; 408; 1056 Participants
N/A N=544 Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
Influenza
Primary: Influenza Vaccine Coverage (Percent) for New Mothers of Newborns — 70; 64 Percentage of Participants
N/A N=65,300 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
Covid19
Primary: Uptake-Total — 14308; 14381 Participants
Phase 4 N=182 Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults
Hepatitis B Vaccine
Primary: Number and Percentage of Participants With Anti-HBs Seroconversion at Month 7 — 75; 69 Participants
N/A N=321 SMS Mobile Technology for Vaccine Coverage and Acceptance
Adherence to Vaccination Schedules
Primary: Completion of 3 Doses of Pentavalent Vaccine — 135; 130 participants
Phase 4 N=276 Efficacy & Safety of Nasal Influenza Immunisation in Children
Influenza Vaccines Efficacy and Safety
Primary: Vaccine Efficacy — 4; 2; 4; 0 Participants
Phase 4 N=480 Immunogenicity of Hepatitis B Vaccination Among Drug Users
Hepatitis B Vaccination
Primary: Number and Rate of Participants With Anti-HBs Seroconversion at Month 7 — 142; 138; 0 Participants
N/A N=3,076 SDH of HPV Vaccine Completion
Human Papilloma Virus
Primary: Overall HPV Vaccine Completion Rates — 1961; 1083 Participants
N/A N=360 Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
COVID-19 · Vaccine Uptake
Primary: COVID Vaccine Uptake at Month 1 — 6; 5 Participants
N/A N=31,265 HPV Vaccine Communication ECHO for Primary Care Clinics
Human Papillomavirus Vaccines · Adolescent Health Services
Primary: HPV Vaccination (≥1 Dose), 11-14 Year Olds at 12 Months — 3189; 3833; 4260 Participants
N/A N=3,827,656 COVID-19 Vaccinations With a Sweepstakes
Covid19
Primary: Weekly Vaccinations Per 100k Residents — 0; -4; 383 Weekly Vaccinations per 100k Residents
N/A N=1,235 Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination
Health Care Utilization · Vaccine Preventable Disease
Primary: Number of Participants Who Completed an Adolescent Well-care Visit — 43; 56; 55 Participants — p=0.165
N/A N=4,455 Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Influenza
Primary: Rates of Confirmed Influenza Illness in Vaccinated and Non-vaccinated Children Attending Schools With and Without School-based Influenza Vaccination Programs — 58.0…
N/A N=608 Enhancing Health Care Access With Cellular Technology
Vaccination
Primary: Immunization Rate — 41.7; 40.1; 50.0 Percentage of immunizations
N/A N=17,446 Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)
Preventive Health Services (PREV HEALTH SERV)
Primary: Child Immunization Status at 19 Months, 0 Days of Age Characterized as Percent Days Under-immunized (DUI) — 32; 24 percentage of days under-immunized — p=0.9